Russo V - Search Results

1

The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies.

Traversari C, Marktel S, Magnani Z, Mangia P, Russo V, Ciceri F, Bonini C, Bordignon C. Traversari C, et al. Among authors: russo v. Blood. 2007 Jun 1;109(11):4708-15. doi: 10.1182/blood-2006-04-015230. Epub 2007 Feb 27. Blood. 2007. PMID: 17327417 Free article. Clinical Trial.

2

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. Russo V, et al. Int J Cancer. 1995 Jun 22;64(3):216-21. doi: 10.1002/ijc.2910640313. Int J Cancer. 1995. PMID: 7622312

3

A family of rapidly evolving genes from the sex reversal critical region in Xp21.

Dabovic B, Zanaria E, Bardoni B, Lisa A, Bordignon C, Russo V, Matessi C, Traversari C, Camerino G. Dabovic B, et al. Among authors: russo v. Mamm Genome. 1995 Sep;6(9):571-80. doi: 10.1007/BF00352360. Mamm Genome. 1995. PMID: 8535061

4

MAGE BAGE and GAGE genes expression in fresh epithelial ovarian carcinomas.

Russo V, Dalerba P, Ricci A, Bonazzi C, Leone BE, Mangioni C, Allavena P, Bordignon C, Traversari C. Russo V, et al. Int J Cancer. 1996 Jul 29;67(3):457-60. doi: 10.1002/(SICI)1097-0215(19960729)67:3<457::AID-IJC24>3.0.CO;2-3. Int J Cancer. 1996. PMID: 8707425 Free article. No abstract available.

5

Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones.

Fleischhauer K, Tanzarella S, Russo V, Sensi ML, van der Bruggen P, Bordignon C, Traversari C. Fleischhauer K, et al. Among authors: russo v. J Immunol. 1997 Sep 1;159(5):2513-21. J Immunol. 1997. PMID: 9278345

6

High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies.

Dalerba P, Ricci A, Russo V, Rigatti D, Nicotra MR, Mottolese M, Bordignon C, Natali PG, Traversari C. Dalerba P, et al. Among authors: russo v. Int J Cancer. 1998 Jul 17;77(2):200-4. doi: 10.1002/(sici)1097-0215(19980717)77:2<200::aid-ijc5>3.0.co;2-u. Int J Cancer. 1998. PMID: 9650552 Free article.

7

Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).

Imro MA, Manici S, Russo V, Consogno G, Bellone M, Rugarli C, Traversari C, Protti MP. Imro MA, et al. Among authors: russo v. Cancer Res. 1999 May 15;59(10):2287-91. Cancer Res. 1999. PMID: 10344730

8

Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.

Tanzarella S, Russo V, Lionello I, Dalerba P, Rigatti D, Bordignon C, Traversari C. Tanzarella S, et al. Among authors: russo v. Cancer Res. 1999 Jun 1;59(11):2668-74. Cancer Res. 1999. PMID: 10363990

9

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.

Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, Villa A, Bordignon C, Traversari C. Russo V, et al. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2185-90. doi: 10.1073/pnas.040540197. Proc Natl Acad Sci U S A. 2000. PMID: 10681453 Free PMC article.

10

Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells.

Russo V, Zhou D, Sartirana C, Rovere P, Villa A, Rossini S, Traversari C, Bordignon C. Russo V, et al. Blood. 2000 Jun 1;95(11):3473-7. Blood. 2000. PMID: 10828031 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,358 results

Search Page